SiPhox Health
At-home blood testing across up to 60 biomarkers with a no-needle upper-arm draw - the lab panel you run from your kitchen, with AI insights and HSA/FSA coverage.
The at-home blood panel that skips the lab visit and the needle: a small upper-arm sample, up to 60 biomarkers, results in 7-10 days with an AI-built action plan. The lowest-friction way to actually test as often as longevity tracking wants you to.
Price: $99–$189 · Verified: 2026-06-13
The at-home blood panel that skips the lab visit and the needle: a small upper-arm sample, up to 60 biomarkers, results in 7-10 days with an AI-built action plan. The lowest-friction way to actually test as often as longevity tracking wants you to.
The hardest part of biomarker tracking is not the science, it is the friction: booking a lab, fasting, driving in, the draw, waiting on a portal. SiPhox removes most of it. You collect a small sample at home with their EasyDraw device (upper arm, no finger prick), mail it back, and get results across up to 60 markers - heart, metabolic, thyroid, hormones, inflammation, kidney, liver, and nutritional status - in about 7-10 days, with an AI summary and a personalized action plan on top.
Where SiPhox fits against the comprehensive platforms: Function Health (160+ markers) and Mito Health (100+) run a wider panel with clinician review, and they are the right pick if you want the broadest one-time snapshot. SiPhox trades panel breadth for frequency and convenience - the no-needle at-home collection and lower entry price make it realistic to test every quarter rather than once a year, which is where biomarker tracking actually earns its value (trend lines, not single points). It is also HSA/FSA eligible, which effectively discounts it 20-37% pre-tax.
The honest framing: SiPhox is testing and insight, not a prescribing relationship. It tells you what your numbers are doing and suggests changes; it does not manage hormones or write prescriptions. For longevity buyers, the clean stack is one comprehensive annual panel (Function or Mito) plus SiPhox for cheaper, more frequent at-home check-ins between draws.
Buyers who want frequent, low-friction biomarker tracking without lab visits or needles, especially anyone testing quarterly to watch trends rather than once a year. HSA/FSA users get a meaningful pre-tax discount.
You want the single broadest one-time panel (Function 160+ or Mito 100+ markers with clinician review), or you need an active prescribing relationship for hormones or GLP-1s - this is testing and insight only.
Specifications
Most often compared with
Where this fits
SiPhox Health At-Home Biomarker Test cross-shops across several editorial surfaces on this site: the full brand catalog, the price band it qualifies for and the in-depth guides for its category.
SiPhox Health At-Home Biomarker Test - buyer FAQ
How is SiPhox different from Function Health or Mito Health?
Breadth vs frequency. Function (160+ markers) and Mito (100+) run a wider panel with clinician review - best for the broadest annual snapshot. SiPhox tests up to 60 markers but collects at home with a no-needle arm draw at a lower entry price, which makes quarterly testing realistic. The longevity-useful signal is the trend over time, so many buyers run one comprehensive annual panel plus SiPhox for cheaper check-ins between draws.
Do I need to go to a lab or get a needle draw?
No. SiPhox uses an at-home EasyDraw device that collects a small sample from your upper arm - no lab visit, no finger prick. You mail it back and results come in about 7-10 days. The first kit typically ships in 3-5 days.
Is SiPhox HSA/FSA eligible, and is it a diagnosis?
It is HSA/FSA eligible, which effectively discounts it 20-37% pre-tax. It is a testing and tracking tool, not a medical diagnosis or treatment: it reports your biomarker values and suggests lifestyle and supplement changes via an AI action plan. Anything that looks off should be reviewed with a qualified clinician.